Rationale and Design of the 'MITOCARE' Study: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRO40303 for the Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction

Dan Atar, Jean-Louis Abitbol, Håkan Arheden, Alain Berdeaux, Jean-Louis Bonnet, Marcus Carlsson, Peter Clemmensen, Valerie Cuvier, Nicolas Danchin, Jean-Luc Dubois-Rande, Henrik Engblom, David Erlinge, Huseyin Firat, Svend Eggert Jensen, Sigrun Halvorsen, Henrik Steen Hansen, Einar Heiberg, Alf-Inge Larsen, Philippe Le Corvoisier, Pascal LongladeJan Erik Nordrehaug, Carole Perez, Rebecca Pruss, Gilles Sonou, Sophie Schaller, Vegard Tuseth, Eric Vicaut

Research output: Contribution to journal › Article › peer-review

218 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Rationale and Design of the 'MITOCARE' Study: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRO40303 for the Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science